Furthermore, we showed that silencing of TOPK abrogated LPS-induced MMP9 promoter-driven transcriptional activity as well as MMP9 protein level, resulting in suppression of breast cancer cell migration or invasion in LPS/TLR4 signaling. The gene discussed is MMP9; the disease is breast carcinoma.